tiprankstipranks

Dyne Therapeutics price target lowered to $46 from $55 at H.C. Wainwright

Dyne Therapeutics price target lowered to $46 from $55 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Dyne Therapeutics (DYN) to $46 from $55 and keeps a Buy rating on the shares. The firm cites the competitive landscape for DYNE-101 and DYNE-251 as well as revised spending assumptions for the target cut.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue